Bio Rad Laboratories Stock Price on November 15, 2024
| BIO Stock | USD 340.53 2.05 0.61% |
Below is the normalized historical share price chart for Bio Rad Laboratories extending back to February 27, 1980. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Bio Rad stands at 340.53, as last reported on the 1st of December, with the highest price reaching 342.29 and the lowest price hitting 337.99 during the day.
If you're considering investing in Bio Stock, it is important to understand the factors that can impact its price. As of now, Bio Stock is very steady. Bio Rad Laboratories secures Sharpe Ratio (or Efficiency) of 0.0239, which signifies that the company had a 0.0239% return per unit of risk over the last 3 months. We have found thirty technical indicators for Bio Rad Laboratories, which you can use to evaluate the volatility of the firm. Please confirm Bio Rad's Mean Deviation of 1.57, downside deviation of 2.41, and Risk Adjusted Performance of 0.0331 to double-check if the risk estimate we provide is consistent with the expected return of 0.0552%.
At this time, Bio Rad's Total Stockholder Equity is very stable compared to the past year. As of the 1st of December 2024, Liabilities And Stockholders Equity is likely to grow to about 12.9 B, while Common Stock Shares Outstanding is likely to drop about 29.1 M. . At this time, Bio Rad's Price To Sales Ratio is very stable compared to the past year. As of the 1st of December 2024, Price Book Value Ratio is likely to grow to 2.15, though Price Earnings Ratio is likely to grow to (14.06). Bio Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 1st of January 1966 | 200 Day MA 317.5767 | 50 Day MA 340.5438 | Beta 0.936 |
Bio |
Sharpe Ratio = 0.0239
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | BIO | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 2.31 actual daily | 20 80% of assets are more volatile |
Expected Return
| 0.06 actual daily | 1 99% of assets have higher returns |
Risk-Adjusted Return
| 0.02 actual daily | 1 99% of assets perform better |
Based on monthly moving average Bio Rad is performing at about 1% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Bio Rad by adding it to a well-diversified portfolio.
Price Book 1.2732 | Enterprise Value Ebitda (13.07) | Price Sales 3.6678 | Shares Float 19.4 M | Wall Street Target Price 402.3333 |
Bio Rad Main Headline on 15th of November 2024
Head to Head Analysis OncoCyte Oruka Therapeutics by thelincolnianonline.com
Oruka Therapeutics and OncoCyte are both small-cap medical companies, but which is the superior investment We will contrast the two businesses based on the strength of their institutional ownership, dividends, analyst recommendations, earnings, risk, profitability and valuation. Institutional and Insider Ownership 56.4 percent of Oruka Therapeutics
Bio Rad Valuation on November 15, 2024
It is possible to determine the worth of Bio Rad on a given historical date. On November 15, 2024 Bio was worth 349.07 at the beginning of the trading date compared to the closed value of 320.31. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Bio Rad stock. Still, in general, we apply an absolute valuation method to find Bio Rad's value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Bio Rad where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Bio Rad's related companies.
| Open | High | Low | Close | Volume | |
| 360.83 | 361.41 | 348.60 | 350.23 | 148,115 | |
11/15/2024 | 349.07 | 349.07 | 319.25 | 320.31 | 286,588 |
| 317.63 | 318.38 | 306.42 | 313.15 | 311,967 |
| Backtest Bio Rad | | | Bio Rad History | | | Bio Rad Valuation | Previous | Next |
Bio Rad Trading Date Momentum on November 15, 2024
| On November 18 2024 Bio Rad Laboratories was traded for 313.15 at the closing time. Highest Bio Rad's price during the trading hours was 318.38 and the lowest price during the day was 306.42 . The net volume was 312 K. The overall trading history on the 18th of November 2024 contributed to the next trading period price depreciation. The overall trading delta to the next next day price was 2.24% . The overall trading delta to current price is 4.58% . |
Bio Rad Laboratories Fundamentals Correlations and Trends
By evaluating Bio Rad's financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Bio Rad's main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Bio financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Bio Rad Stock history
Bio Rad investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Bio is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Bio Rad Laboratories will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Bio Rad stock prices may prove useful in developing a viable investing in Bio Rad
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 29.2 M | 29.1 M | |
| Net Loss | -4.2 B | -4 B |
Bio Rad Quarterly Net Working Capital |
|
Bio Rad Stock Technical Analysis
Bio Rad technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Bio Rad Period Price Range
Low | December 1, 2024
| High |
0.00 | 0.00 |
Bio Rad Laboratories cannot be verified against its exchange. Please verify the symbol is currently traded on New York Stock Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Bio Rad December 1, 2024 Market Strength
Market strength indicators help investors to evaluate how Bio Rad stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Bio Rad shares will generate the highest return on investment. By undertsting and applying Bio Rad stock market strength indicators, traders can identify Bio Rad Laboratories entry and exit signals to maximize returns
Bio Rad Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Bio Rad's price direction in advance. Along with the technical and fundamental analysis of Bio Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Bio to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.0331 | |||
| Jensen Alpha | (0.01) | |||
| Total Risk Alpha | (0.31) | |||
| Sortino Ratio | (0.02) | |||
| Treynor Ratio | 0.1188 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Bio Rad Laboratories. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product. You can also try the Analyst Advice module to analyst recommendations and target price estimates broken down by several categories.
Is Life Sciences Tools & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Bio Rad. If investors know Bio will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Bio Rad listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 5.412 | Earnings Share (28.09) | Revenue Per Share 90.815 | Quarterly Revenue Growth 0.028 | Return On Assets 0.0186 |
The market value of Bio Rad Laboratories is measured differently than its book value, which is the value of Bio that is recorded on the company's balance sheet. Investors also form their own opinion of Bio Rad's value that differs from its market value or its book value, called intrinsic value, which is Bio Rad's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Bio Rad's market value can be influenced by many factors that don't directly affect Bio Rad's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Bio Rad's value and its price as these two are different measures arrived at by different means. Investors typically determine if Bio Rad is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Bio Rad's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.